WinSanTor
PrivateLast Round
SAFE
Apr 29, 2024
Est. Valuation
$25M
Total Funding Raised
$16.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
WinSanTor is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic, chemotherapy-induced, and HIV-induced peripheral neuropathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WinSanTor Comparables
Compare WinSanTor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regenacy Pharmaceuticals | 84% | |
| AlgoTx | 78% | |
| Novaremed AG | 78% | |
WinSanTor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Apr 29, 2024 | ||||
| Crowdfunding | Apr 1, 2024 | ||||
| Debt | Nov 1, 2023 | ||||
| SAFE | Oct 1, 2023 | ||||
| SAFE | Sep 1, 2023 | ||||
Debt | Jun 1, 2023 |
Key People
Founding team and executive leadership
WinSanTor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Thynk Capital | VC Round |
| Methuselah Foundation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 48% MoM.
- Apr 1, 2024
$707K raised in crowdfunding round.
WinSanTor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about WinSanTor's valuation, stock price, and market status.